Long-term Outcomes in Patients With COVID-19
1 other identifier
observational
900
1 country
1
Brief Summary
Long-term outcomes from coronavirus disease 2019 (COVID-19) are currently unknown. This study will collect daily living status of survivors of COVID-19.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 8, 2020
CompletedStudy Start
First participant enrolled
August 10, 2020
CompletedFirst Posted
Study publicly available on registry
August 11, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
August 31, 2021
CompletedOctober 23, 2020
October 1, 2020
1.1 years
August 8, 2020
October 22, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Physical functions
Physical functions will be assessed using Activities of daily living (ADL) scale. Minimum value:0, Maximum value: 100. Higher scores mean a better outcome.
4-6 months
Respiratory function
Respiratory function will be assessed using modified Medical Research Council(mMRC) scale. Minimum value:0, Maximum value: 4. Higher scores mean a worse outcome.
4-6 months
Cognitive function
Cognitive function will be assessed using modified Telephone Interview for Cognitive Status (TICS-m) scale. Minimum value:0, Maximum value: 50. Higher scores mean a better outcome.
4-6 months
Depression status
Depression status will be assessed using Zung Self-rating Depression Scale(SDS). Minimum value:25, Maximum value: 125. Higher scores mean a worse outcome.
4-6 months
Sensory functions
Sensory functions will be assessed using Carcinologic Handicap Index (CHI). Minimum value:0, Maximum value: 144. Higher scores mean a worse outcome.
4-6 months
Heart function
Heart function will be assessed using New York Heart Association (NYHA) functional class. Minimum value:1, Maximum value: 4. Higher scores mean a worse outcome.
4-6 months
Eligibility Criteria
This study will enroll survivors of COVID-19 aged over 18 years old who had been admitted in Leishenshan Hospital for COVID-19 patients in Wuhan, China.
You may qualify if:
- Survivors who had been admitted in Leishenshan Hospital for COVID-19 patients in Wuhan, China
You may not qualify if:
- Patients who were \< 18 years
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- RenJi Hospitallead
Study Sites (1)
Renji Hospital, Shanghai Jiaotong University School of Medicine
Pudong, Shanghai Municipality, 200127, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Weifeng Yu, MD,PhD
Renji Hospital, School of Medicine, Shanghai Jiaotong University, China
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Target Duration
- 6 Months
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 8, 2020
First Posted
August 11, 2020
Study Start
August 10, 2020
Primary Completion
August 31, 2021
Study Completion
August 31, 2021
Last Updated
October 23, 2020
Record last verified: 2020-10